Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Fda Inspections
  6. /
  7. Novo Nordisk A/S
FDA Inspection
•Novo Nordisk A/S•May 4, 2023

Novo Nordisk A/S – FDA Inspection, May 4, 2023

Record Details

This FDA Inspection record concerns Novo Nordisk A/S, with an inspection on May 4, 2023, issued by the Center for Biologics Evaluation and Research, covering biologics.

Company
Novo Nordisk A/S
Inspection Date
May 4, 2023
Product Type
Biologics
Office
Center for Biologics Evaluation and Research
People
  • Mikhail V. Ovanesov
  • Prabhu P. Raju (FDA Associated Person)
  • Unnee Ranjan (FDA Associated Person)
View Company Profile

ID · 66074870-de76-43e2-b8fd-c93d30311f61

Inspection Facts

Voluntary Action Indicated (VAI)

Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.

Inspection number
1209127
FDA center
Biologics
Project area
Blood and Blood Products
Outcome
Form 483 issued

Other FDA inspections of Novo Nordisk A/S

10
DateClassificationOfficeProject area
March 25, 2024Not classifiedOffice of Inspections and Investigations
December 2, 2022VAICenter for Drug Evaluation and ResearchDrug Quality Assurance
September 6, 2019NAICenter for Drug Evaluation and ResearchDrug Quality Assurance
March 7, 2018Not classifiedOffice of Inspections and Investigations
August 29, 2017NAICenter for Drug Evaluation and ResearchDrug Quality Assurance
View all 10 other inspections on the company page
Other documents for Novo Nordisk A/S
  • FDA Inspection 1269488 - 2024-03-25
  • FDA Inspection 1230597 - 2022-12-02
  • FDA Inspection 1107225 - 2019-09-06
  • FDA Inspection 1044502 - 2018-03-07
  • FDA Inspection 1028554 - 2017-08-29

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Novo Nordisk A/S
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.